Therapeutics Acquisition Corp. (RACA) Stock Analysis

What Therapeutics Acquisition Corp. does

Therapeutics Acquisition Corp., which operates as Research Alliance Corp. I, was founded in 2020 and is headquartered in Boston, Massachusetts. Its core mission is to pursue a business combination, including but not limited to mergers, capital stock exchanges, asset acquisitions, share purchases, or reorganizations, with one or more enterprises in the United States healthcare sector.

Key metrics

ETFs linked to RACA

Broad-market and Financial Services sector ETFs an investor holding Therapeutics Acquisition Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how RACA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Therapeutics Acquisition Corp.?

Therapeutics Acquisition Corp. trades under the ticker RACA on NASDAQ.

Which exchange is RACA listed on?

RACA is listed on NASDAQ.

What sector does Therapeutics Acquisition Corp. operate in?

Therapeutics Acquisition Corp. is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze RACA in a portfolio?

PortView shows RACA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.